Skip to Main Content

Author Details

Anna L Brown
Adelaide Medical School, University of Adelaide
2003
68
29
PMIDPaper TitleJournal TitlePublished Year
36031433Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.Pathology2023
37041128TP53 mutation variant allele frequency of â¿¥10% is associated with poor prognosis in therapy-related myeloid neoplasms.Blood Cancer J2023
37377909Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.Front Oncol2023
37406166Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.Blood Adv2023
36626254Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26.Blood2023
36574363TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.Blood2023
36001442Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.Blood Adv2023
34658019Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges.Br J Haematol2022
35551192Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
35383280Cell environment shapes TDP-43 function with implications in neuronal and muscle disease.Commun Biol2022
35443029Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.Blood2022
35840577Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
36130297Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.Blood2022
35201331And the germline beat (AML) goes on.Blood2022
35197628TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.Nature2022
33272691Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative.Pathology2021
33850299Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.Leukemia2021
34521114Childhood acute myeloid leukemia shows a high level of germline predisposition.Blood2021
34424323B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations.Blood Adv2021
34623329To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition.J Clin Invest2021
34387894GATA2 deficiency syndrome: A decade of discovery.Hum Mutat2021
34274995HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing.Acta Neuropathol2021
34233450The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.Haematologica2021
34162872Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer.Nat Commun2021
32479602FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention.Nucleic Acids Res2020
31647332Correct application of variant classification guidelines in germline <i>RUNX1</i> mutated disorders to assist clinical diagnosis.Leuk Lymphoma2020
32066420Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss.BMC Med Genet2020
32771235What's germane in the germline? Finding clinically relevant germline variants in myeloid neoplasms from tumor only screening.Leuk Res2020
32790644Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.J Clin Invest2020
32208489RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.Blood Adv2020
32488879A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.Br J Haematol2020
32430494Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).Blood2020
32483558Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.Cell Rep Med2020
31089247The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.Leukemia2019
31648317ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.Blood Adv2019
30926971Genomic subtyping and therapeutic targeting of acute erythroleukemia.Nat Genet2019
30840888APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors.Cell Rep2019
30923096A novel germline <i>SAMD9L</i> mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia.Haematologica2019
28642594Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes.Leukemia2018
29891941Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia.Blood Cancer J2018
29967129Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.Blood2018
28674423A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.Leukemia2018
28547672Myeloid neoplasms with germline DDX41 mutation.Int J Hematol2017
28637623DDX41-related myeloid neoplasia.Semin Hematol2017
28637618Recognition of familial myeloid neoplasia in adults.Semin Hematol2017
26712909Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.Blood2016
27207790Conditional knockout mice demonstrate function of Klf5 as a myeloid transcription factor.Blood2016
27322744Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia.Nat Med2016
26859074Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia.Leukemia2016
25748685A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone.Leukemia2015
  • 1 - 50 of 68

Recommended Authors

Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 8
Ninad Oak
St. Jude Children's Research Hospital
Career Start Year 2014
Number of shared co-authors 7
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 8
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 4
Il??ana Antony-Debr??
INSERM, France Villejuif Universite Paris-Saclay
Career Start Year 2011
Number of shared co-authors 3
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 7
Kevin Watanabe-Smith
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 6
Tamara L Lamprecht
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 9
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 7
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 5
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 3
Felicitas Thol
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 20
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
Kilannin Krysiak
Washington University School of Medicine
Career Start Year 2007
Number of shared co-authors 5
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 11
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 3
Michelle O'Laughlin
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 3
Sharon E Heath
Washington University School of Medicine.
Career Start Year 2003
Number of shared co-authors 4
Peter J Campbell
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 9
Gudrun G??hring
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 11
Fei Yang
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 4
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 3
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 3
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 8
Doris Steinemann
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 10
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 15
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 21
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 10
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 27
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 8

Collaborators

Lucy A Godley
The University of Chicago
Co-authored papers 10
Nicola K Poplawski
Royal Adelaide Hospital
Co-authored papers 7
Kerry Phillips
Royal Adelaide Hospital
Co-authored papers 6
Luca Malcovati
University of Pavia & S. Matteo Hospital
Co-authored papers 5
Courtney D DiNardo
UT MD Anderson Cancer Center
Co-authored papers 4
Francine E Garrett-Bakelman
University of Virginia
Co-authored papers 3
Paul G Ekert
Co-authored papers 3
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Co-authored papers 3
Ari Melnick
Co-authored papers 3
Mahmoud A Bassal
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 3
Javed Khan
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Simone Feurstein
University Hospital Heidelberg
Co-authored papers 3
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 3
Jeffery M Klco
St. Jude Children's Research Hospital
Co-authored papers 3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Sheng Li
Co-authored papers 3
Lesley Rawlings
Co-authored papers 3
Mignon L Loh
University of Washington
Co-authored papers 2
Rémi Favier
Co-authored papers 2
Jun S Wei
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Michael E Ward
National Institute of Neurological, National Institutes of Health (NIH)
Co-authored papers 2
Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Udayan Guha
Co-authored papers 2
Shaojian Gao
Co-authored papers 2
Ravindra Majeti
Stanford University School of Medicine
Co-authored papers 2
David Wu
University of Washington
Co-authored papers 2
Siob??n B Keel
University of Washington School of Medicine
Co-authored papers 2
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 2
Naseema Gangat
Mayo Clinic
Co-authored papers 2
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 2
Release 1.2